<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03111550</url>
  </required_header>
  <id_info>
    <org_study_id>EDOF-121-NGPC</org_study_id>
    <nct_id>NCT03111550</nct_id>
  </id_info>
  <brief_title>Clinical Investigation of the Next-Generation Intraocular Lens</brief_title>
  <official_title>Clinical Investigation of the TECNIS Next-Generation Intraocular Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Medical Optics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Medical Optics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a 6-month, prospective, multicenter, bilateral, randomized clinical
      investigation of the TECNIS Model ZHR00 and Model ZQR00 IOLs versus the TECNIS Symfony
      control IOL.

      The study was conducted at 12 sites in the U.S.A and treated approximately 240 subjects,
      equally split between the two test groups and the control group.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 10, 2017</start_date>
  <completion_date type="Actual">February 23, 2018</completion_date>
  <primary_completion_date type="Actual">February 23, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>subject/evaluator-masked</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Near Visual Acuity</measure>
    <time_frame>1month</time_frame>
    <description>Visual acuity at near distance</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse Events Rate</measure>
    <time_frame>6 months</time_frame>
    <description>Rate of adverse events reported as compared to ISO SPE rates</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">242</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Investigational Lens Device #1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Investigational Intraocular Lens Device #1: Tecnis Model ZHR00</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Investigational Lens Device #2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Investigational Intraocular Lens Device #2: Tecnis Model ZQR00</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Device</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Control TECNIS Symfony® Extended Range of Vision Intraocular Lens: Model ZXR00</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Investigational Intraocular Lens Device #1: TECNIS Model ZHR00</intervention_name>
    <description>Intraocular lens replaces the natural lens removed during cataract surgery.</description>
    <arm_group_label>Investigational Lens Device #1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Investigational Intraocular Lens Device #2: TECNIS Model ZQR00</intervention_name>
    <description>Intraocular lens replaces the natural lens removed during cataract surgery.</description>
    <arm_group_label>Investigational Lens Device #2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TECNIS Symfony® Extended Range of Vision Intraocular Lens: Model ZXR00</intervention_name>
    <description>Intraocular lens replaces the natural lens removed during cataract surgery.</description>
    <arm_group_label>Control Device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Bilateral cataracts

          -  Potential for postoperative BCDVA of 20/30 Snellen or better

          -  Corneal astigmatism of 1.00 D or less in both eyes

          -  Normal corneal topography

          -  Clear intraocular media other than cataract in each eye

          -  Signed informed consent and HIPAA authorization or equivalent documentation necessary
             to comply with applicable privacy laws pertaining to medical treatment in the
             governing countries

        Exclusion Criteria:

          -  Any clinically-significant pupil abnormalities (non-reactive, fixed pupils, or
             abnormally-shaped pupils)

          -  Irregular corneal astigmatism

          -  Inability to focus or fixate for prolonged periods of time (e.g., due to strabismus,
             nystagmus, etc.)

          -  Prior corneal refractive (LASIK, LASEK, RK, PRK, etc.) or intraocular surgery

          -  Corneal abnormalities such as stromal, epithelial or endothelial dystrophies that are
             predicted to cause visual acuity losses to a level worse than 20/30 Snellen during the
             study

          -  Inability to achieve keratometric stability for contact lens wearers

          -  Recent ocular trauma or ocular surgery that is not resolved/stable or may affect
             visual outcomes or increase risk to the subject

          -  Subjects with diagnosed degenerative visual disorders

          -  Subjects with conditions associated with increased risk of zonular rupture, including
             capsular or zonular abnormalities that may lead to IOL decentration or tilt, such as
             pseudoexfoliation, trauma, or posterior capsule defects

          -  Use of systemic or ocular medications that may affect vision

          -  Prior, current, or anticipated use of tamsulosin or silodosin

          -  Poorly-controlled diabetes

          -  Acute, chronic, or uncontrolled systemic or ocular disease or illness

          -  Known ocular disease or pathology that may affect visual acuity or may require
             surgical intervention during the course of the study or may be expected to require
             retinal laser treatment or other surgical intervention during the course of the study

          -  Patient is pregnant, plans to become pregnant, is lactating or has another condition
             associated with the fluctuation of hormones that could lead to refractive changes

          -  Concurrent participation or participation within 45 days prior to preoperative visit
             in any other clinical trial

          -  Desire for monovision correction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Devi Priya Janakiraman, OD,FAAO</last_name>
    <role>Study Director</role>
    <affiliation>Abbott Medical Optics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Empire Eye and Laser Center</name>
      <address>
        <city>Bakersfield</city>
        <state>California</state>
        <zip>93309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Assil Eye Institute</name>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <zip>90210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jones Eye Care</name>
      <address>
        <city>Sioux City</city>
        <state>Iowa</state>
        <zip>51104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chesapeake Eye Care and Laser</name>
      <address>
        <city>Annapolis</city>
        <state>Maryland</state>
        <zip>21401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eye Doctors of Washington</name>
      <address>
        <city>Chevy Chase</city>
        <state>Maryland</state>
        <zip>20815</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ophthalmology Consultants LTD</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scott and Christie and Associates,PC</name>
      <address>
        <city>Cranberry Township</city>
        <state>Pennsylvania</state>
        <zip>16066</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolina Cataract and Laser Center</name>
      <address>
        <city>Ladson</city>
        <state>South Carolina</state>
        <zip>29456</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vance Thompson Vision</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Loden Vision Centers</name>
      <address>
        <city>Goodlettsville</city>
        <state>Tennessee</state>
        <zip>37072</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Key-Whitman Eye Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75243</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Eye and Laser Center</name>
      <address>
        <city>Hurst</city>
        <state>Texas</state>
        <zip>76054</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>April 7, 2017</study_first_submitted>
  <study_first_submitted_qc>April 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 13, 2017</study_first_posted>
  <disposition_first_submitted>February 11, 2019</disposition_first_submitted>
  <disposition_first_submitted_qc>March 1, 2019</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">July 1, 2020</disposition_first_posted>
  <last_update_submitted>June 29, 2020</last_update_submitted>
  <last_update_submitted_qc>June 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>July 6, 2020</submitted>
    <returned>July 21, 2020</returned>
  </pending_results>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

